
HMC · NYSE
The stated consensus is Hold, supported by seven analysts, with a mean target of $32.40; the low and high targets are not supplied, so the target spread cannot be measured. The most bullish and least bullish named analysts are also unavailable because no individual analyst recommendations are identified. Other supplied aggregation pages show materially different averages, including $28.28 at Investing.com, $29.69 at ChartMill, and $30.91 at Financhill and another Investing.com page, with one Investing.com snippet showing a $32 high and $29.82849 low. No attributable rating or target revisions were reported during the week. The substantive disagreement is whether valuation and momentum justify upside or whether current pricing already reflects the opportunity.